Yield10 Bioscience Inc (NASDAQ:YTEN) traded down 16.7% on Tuesday . The company traded as low as $0.15 and last traded at $0.15, 7,711,321 shares traded hands during trading. An increase of 1,841% from the average session volume of 397,352 shares. The stock had previously closed at $0.18.

A number of analysts have recently issued reports on YTEN shares. National Securities cut Yield10 Bioscience from a “buy” rating to a “neutral” rating in a research report on Monday, November 18th. Aegis reissued a “buy” rating and set a $2.00 target price on shares of Yield10 Bioscience in a report on Tuesday, August 13th. Maxim Group reissued a “buy” rating and set a $0.50 target price on shares of Yield10 Bioscience in a report on Friday, November 15th. Finally, Zacks Investment Research restated a “hold” rating on shares of Yield10 Bioscience in a research note on Saturday, October 19th.

The company’s 50-day moving average price is $0.33 and its two-hundred day moving average price is $0.70. The company has a debt-to-equity ratio of 1.93, a current ratio of 1.99 and a quick ratio of 1.99. The company has a market capitalization of $1.78 million, a P/E ratio of -0.15 and a beta of 2.96.

Yield10 Bioscience (NASDAQ:YTEN) last announced its earnings results on Tuesday, November 12th. The specialty chemicals company reported ($0.16) EPS for the quarter, hitting the consensus estimate of ($0.16). Yield10 Bioscience had a negative net margin of 995.38% and a negative return on equity of 168.01%. The business had revenue of $0.22 million during the quarter. On average, analysts anticipate that Yield10 Bioscience Inc will post -0.66 earnings per share for the current fiscal year.

A hedge fund recently raised its stake in Yield10 Bioscience stock. Renaissance Technologies LLC raised its position in shares of Yield10 Bioscience Inc (NASDAQ:YTEN) by 9.5% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 478,176 shares of the specialty chemicals company’s stock after acquiring an additional 41,500 shares during the period. Renaissance Technologies LLC owned approximately 3.83% of Yield10 Bioscience worth $463,000 at the end of the most recent quarter. 7.58% of the stock is currently owned by institutional investors and hedge funds.

About Yield10 Bioscience (NASDAQ:YTEN)

Yield10 Bioscience, Inc, an agricultural bioscience company, engages in developing disruptive technologies for enhancing crop yield in the United States and Canada. The company, through its Smart Carbon Grid for Crops and T3 platforms, is involved in improving fundamental crop yield through enhanced photosynthetic carbon capture, as well as increased carbon utilization efficiency to increase seed yield.

Featured Article: Marijuana Stocks

Receive News & Ratings for Yield10 Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Yield10 Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.